Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trial

NCT06107062 is registered in ClinicalTrials.gov with University of Colorado, Boulder as lead sponsor.

NCT NCT06107062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06107062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trial
Lead sponsor
University of Colorado, Boulder
Phase
Phase 2
Overall status
Recruiting
Start date
July 26, 2024
Completion date
March 31, 2029
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder